ACTAVIS SPECIALTY BRANDS
DEAD

Serial Number

85839782

Owner

ALLERGAN SALES, LLC

Attorney

GABRIELLE S. ROTH

Filing Date

Feb 4, 2013

Add to watchlist:

No watchlists yet
View on USPTO

ACTAVIS SPECIALTY BRANDS Trademark

Serial Number: 85839782

ACTAVIS SPECIALTY BRANDS is a trademark filed by ALLERGAN SALES, LLC on February 4, 2013. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

ALLERGAN SALES, LLC (494 trademarks)

5 GIRALDA FARMS
MADISON, NJ 07940

Entity Type: 16

ACTAVIS, INC. (216 trademarks)

400 INTERPACE PARKWAY
PARSIPPANY, NJ 07054

Entity Type: 03

Trademark Details

Filing Date

February 4, 2013

Registration Date

Not Registered

Published for Opposition

July 23, 2013

Goods & Services

Pharmaceuticals, namely, ACE inhibitors, Acid reflux medications, ADHD medications, analgesics, antacids and calcium supplements, Anti-anxiety medications, Anti-arrhythmic medications, Anti-asthmatic medications, antibiotics, anticholinergic medications, Antidepressants, diabetic medications, Anti-diuretic medications, Anti-fungal medications, Antihistamines, Anti-malarial medications, Anti-nausea medications, Appetite suppressants, Benign prostatic hyperplasia medications, Beta blockers, calcium channel blockers, cardiovascular disease medications, Chemotherapy medications, Chronic obstructive pulmonary disease medications, condyloma medications, electrolyte replacement solution for oral rehydration, gallstone dissolution; pharmaceutical preparations for treatment for genital warts, hormone replacement therapy, Hypertensive agents, Hyperuricemia medications, Hypolipidemia medications, Immunosuppressants, pharmaceutical preparations for treatment of diseases of the skin, namely, dermatitis, eczema and psoriasis, Iron chelating medications, iron deficiency and anemia medications, laxatives, multivitamin and mineral supplements, Muscle relaxants, nasal decongestants, NSAIDs, oral contraceptives, Osteoporosis medications, Pain medications, pharmaceutical preparations for treatment of painful and difficult urination, preparations for the treatment of overactive bladder, topical corticosteroids, Vasodilators, Proton pump inhibitors, Hypokalemia medications, Uricosuric medications, and Gastrointestinal medications; all the foregoing specifically excluding tissue plasminogen activators

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 3, 2018 ASGN
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Oct 5, 2015 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 5, 2015 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 3, 2015 NOAM
TTAB RELEASE CASE TO TRADEMARKS
Jan 22, 2015 TMBN
OPPOSITION TERMINATED NO. 999999
Jan 22, 2015 OP.T
OPPOSITION DISMISSED NO. 999999
Jan 6, 2015 OP.D
OPPOSITION INSTITUTED NO. 999999
Jan 21, 2014 OP.I
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 6, 2013 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 6, 2013 REAP
EXTENSION OF TIME TO OPPOSE RECEIVED
Aug 16, 2013 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 23, 2013 NPUB
PUBLISHED FOR OPPOSITION
Jul 23, 2013 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 3, 2013 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 15, 2013 PREV
ASSIGNED TO LIE
Jun 15, 2013 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
May 30, 2013 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 24, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 23, 2013 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 23, 2013 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 20, 2013 GNRN
NON-FINAL ACTION E-MAILED
May 20, 2013 GNRT
NON-FINAL ACTION WRITTEN
May 20, 2013 CNRT
ASSIGNED TO EXAMINER
May 13, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 8, 2013 NWOS
NEW APPLICATION ENTERED
Feb 7, 2013 NWAP